Literature DB >> 2936428

In vivo treatment with GM1 prevents the rapid decay of ATPase activities and mitochondrial damage in hippocampal slices.

R Bianchi, D Janigro, F Milan, G Giudici, A Gorio.   

Abstract

Slices from rat CA3 hippocampal area show a 30% decrement in ATPase activity after 35 min of 'in vitro' incubation. Such a drop is accompanied by an alteration of mitochondrial ultrastructure. However, if rats are treated daily with GM1 ganglioside (10 mg/kg during 3 days) both phenomena are fully prevented. These results would suggest a protective effect of gangliosides onto membrane structures under stress conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936428     DOI: 10.1016/0006-8993(86)90856-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats: effect of ganglioside treatment.

Authors:  P Marini; M Vitadello; R Bianchi; C Triban; A Gorio
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

2.  Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations.

Authors:  K L Hallene; E Oby; B J Lee; S Santaguida; S Bassanini; M Cipolla; N Marchi; M Hossain; G Battaglia; D Janigro
Journal:  Neuroscience       Date:  2006-07-20       Impact factor: 3.590

3.  GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding.

Authors:  Jay S Schneider; Franca Cambi; Stephen M Gollomp; Hiroto Kuwabara; James R Brašić; Benjamin Leiby; Stephanie Sendek; Dean F Wong
Journal:  J Neurol Sci       Date:  2015-06-16       Impact factor: 3.181

4.  A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients.

Authors:  Jay S Schneider; Stephen M Gollomp; Stephanie Sendek; Amy Colcher; Franca Cambi; Wei Du
Journal:  J Neurol Sci       Date:  2012-11-28       Impact factor: 3.181

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.